The relationship between symptomatic and functional changes of Korean children and adolescents with attention deficit hyperactivity disorder treated with OROS methylphenidate

被引:0
|
作者
Lee, S. [1 ]
Kim, E. [1 ]
Cheon, K. [1 ]
Song, D. [1 ]
机构
[1] Yonsei Univ, Coll Med, Seoul, South Korea
关键词
OROS-MPH; ADHD; Symptoms; Functioning; Life Participation Scale;
D O I
暂无
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
PS-109
引用
收藏
页码:S170 / S170
页数:1
相关论文
共 50 条
  • [41] Neurofeedback vs. Methylphenidate for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents
    Abenia Abenia, Ma Isabel
    Jimenez-Muro Franco, Adriana
    CUADERNOS DE NEUROPSICOLOGIA-PANAMERICAN JOURNAL OF NEUROPSYCHOLOGY, 2019, 13 (02): : 171 - 181
  • [42] Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Pieter J. Hoekstra
    Jan K. Buitelaar
    European Child & Adolescent Psychiatry, 2016, 25 : 339 - 340
  • [43] Effects of methylphenidate in auditory processing evaluation of children and adolescents with attention deficit hyperactivity disorder
    Cavadas, Marcia
    Pereira, Liliane Desgualdo
    Mattos, Paulo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (01) : 138 - 143
  • [44] Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder
    Arabgol, Fariba
    Panaghi, Leily
    Hebrani, Paria
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2009, 18 (01) : 53 - 59
  • [45] Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?
    Hoekstra, Pieter J.
    Buitelaar, Jan K.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2016, 25 (04) : 339 - 340
  • [46] Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder
    Fariba Arabgol
    Leily Panaghi
    Paria Hebrani
    European Child & Adolescent Psychiatry, 2009, 18 : 53 - 59
  • [47] Effect of Methylphenidate on Height and Weight in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review
    Kim, Hyo-Won
    Kim, Seon-Ok
    Shon, Seunghyun
    Lee, Jung-Sun
    Lee, Hyun-Jeong
    Choi, Jin-Ho
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (08) : 448 - 453
  • [48] Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder
    Hammerness, Paul
    Wilens, Timothy
    Mick, Eric
    Spencer, Thomas
    Doyle, Robert
    McCreary, Michelle
    Becker, Judith
    Biederman, Joseph
    JOURNAL OF PEDIATRICS, 2009, 155 (01): : 84 - 89
  • [49] Attention deficit hyperactivity disorder in children and adolescents
    Flisher, A. J.
    Hawkridge, S.
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2013, 19 (03) : 136 - 140
  • [50] Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy
    Gonzalez-Heydrich, Joseph
    Whitney, Jane
    Waber, Deborah
    Forbes, Peter
    Hsin, Olivia
    Faraone, Stephen V.
    Dodds, Alice
    Rao, Sneha
    Mrakotsky, Christine
    MacMillan, Carlene
    DeMaso, David R.
    de Moor, Carl
    Torres, Alcy
    Bourgeois, Blaise
    Biederman, Joseph
    EPILEPSY & BEHAVIOR, 2010, 18 (03) : 229 - 237